INDBInternet News Database 2.5 Updated 2 min ago · 293 sources Show or hide images Light or dark

Results for “Weight-Loss Drugs The”

Health
1 source

Who is covering this

BBC NewsCenter
Truth score 46
Centre 100%100%
BBC NewsCenter

NHS Western Isles prescribing weight loss drugs at triple the rate of other health boards

A new report finds "significant variation" between Scotland's health boards prescribing new medicines.

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
Full coverage
Coverage breakdown
Funding
Public broadcaster100%
Countries
United Kingdom100%
Media ownership
BBC (UK Government)100%
Avg reliability90
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 46 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 90 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Science
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

McDonald's testing revamped menu amid the explosion of new weight loss drugs - weeks after Diet Coke was brought back to Aussie stores

An investors meeting earlier this month revealed McDonald's is considering new menu items.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Business
1 source

Who is covering this

NewsCenter
Truth score 38
Centre 100%100%
NewsCenter

Who should prescribe weight loss drugs? IFSO says doctors’ competence, not speciality, should decide

Who should prescribe weight loss drugs? IFSO says doctors’ competence, not speciality, should decide The South First

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 8 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
2 sources

Who is covering this

CNBCCenterTaipei TimesCenter
Truth score 52
Centre 100%100%
CNBCCenter

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

Lean: Center Fact-focusedFactuality: HighCountry: United StatesFunding: Corporate
Full coverage
Coverage breakdown
Funding
Corporate50%
Private50%
Countries
Taiwan50%
United States50%
Media ownership
Liberty Times Group50%
CNBC50%
Avg reliability78
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 52 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 78 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 3 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Business
1 source

Who is covering this

The GuardianLeft
Truth score 45
Left 100%100%
The GuardianLeft

Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn

GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment The gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms’ attention away from diabetes...

Lean: Left Fact-focusedFactuality: Very highCountry: United KingdomFunding: Nonprofit trustOwner: Scott Trust
Full coverage
Coverage breakdown
Funding
Nonprofit trust100%
Countries
United Kingdom100%
Media ownership
Scott Trust100%
Avg reliability85
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 45 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 85 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
27 sources

Who is covering this

Associated PressCenterPBS NewsHourLeans leftBBC NewsCenterThe GuardianLeftCBS NewsLeans leftNBC NewsLeans leftABC News (US)Leans leftSky NewsLeans rightCNBCCenterThe HinduLeans leftUSA TODAYLeans leftThe HillCenterCNNLeftGoogle NewsCenterNDTVCenterQuartzLeans leftGizmodoLeans leftMedpagetodayCenterTimes of IndiaCenterMedscapeCenterNew York PostRightZero HedgeRightWSNS-TVNot ratedThe Seattle TimesNot ratedKING-TVNot ratedAll 27 outlets
Truth score 9110
Left 45%45%Centre 41%41%Right 14%14%
BBC NewsCenter

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION. Companies making popular weight loss drugs, including Ozempic and Wegovy, will be required to...

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: Public broadcasterOwner: BBC (UK Government)
+ 34 · Full coverage
Coverage breakdown
Funding
Corporate59%
Not recorded19%
Public broadcaster7%
Private7%
Nonprofit4%
Countries
United States78%
India11%
United Kingdom11%
Media ownership
Independent19%
Comcast12%
G/O Media12%
WSNS-TV6%
Google News6%
Avg reliability75
Low-credibility share4%
Fact / opinion39/0
State media0%
More analysis
Truth score: 91 (Strongly corroborated) Propaganda risk: 0 Trending: Low Sources: 27 Reliability: 75 Bias severity: 54 Risk: 4Sentiment: -95Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
2 sources

Who is covering this

ReutersCenterCNBCCenter
Truth score 551
Centre 100%100%
ReutersCenter

Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump

Eli Lilly lifts revenue outlook as weight-loss shot demand soars, shares jump Reuters

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
  • CNBC Eli Lilly CEO on affordable access to obesity drugs for seniors

    Eli Lilly CEO Dave Ricks talks with CNBC about working with the Trump administration to provide obesity drugs at lower costs for seniors. The company on Thursday reported third-quarter earnings and revenue that blew...

    Lean: Center VideoFactuality: HighCountry: United StatesFunding: Corporate
+ 1 · Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States50%
United Kingdom50%
Media ownership
CNBC50%
Thomson Reuters50%
Avg reliability86
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 55 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 86 Bias severity: 0 Risk: 0Sentiment: -33Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
1 source

Who is covering this

Daily MailCenter
Truth score 37
Centre 100%100%
Daily MailCenter

DR SAIRA BANO: Why I'll be switching many of my patients to Reta as soon as I can - the new weight-loss drug is the only hope for those unable to get over the 'Mounjaro plateau'

It is easy to forget how quickly the world of weight loss has changed. Five years ago there was no such thing as a truly effective treatment for obesity.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: DMGT
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
DMGT100%
Avg reliability63
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 63 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 16 Amplification: 0

How we score

Analyze: Story Timeline
Like
Health
4 sources

Who is covering this

ABC News (Australia)CenterNBC NewsLeans leftThe Sydney Morning HeraldLeans leftMedscapeCenter
Truth score 672
Left 50%50%Centre 50%50%
ABC News (Australia)Center

TGA clears weight loss tablets for use in Australia

A daily Wegovy tablet has been cleared for use in Australia, with the weight loss tablet expected to hit shelves before Christmas. Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to...

Lean: Center Fact-focusedFactuality: Very highCountry: AustraliaFunding: Public broadcasterOwner: Australian Government
  • NBC News New Weight Loss Drug Could Also Treat Knee Arthritis: Study

    A recent poll found about 1-in-8 American adults say they’re currently taking GLP-1 weight loss drugs and now a study in The England Journal of Medicine finds that one drug, retatrutide, currently in trials, could...

    Lean: Leans left VideoFactuality: HighCountry: United StatesFunding: CorporateOwner: Comcast
  • Medscape Keeping the Weight Off After Stopping a GLP-1

    Weight regain is common after GLP-1 discontinuation. Experts discuss strategies that may help patients maintain their weight loss.

    Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
  • The Sydney Morning Herald First GLP-1 weight loss pill in Australia to hit market by end of the year

    Wegovy’s GLP-1 weight loss tablet has been approved in Australia for the first time, expected to lead to a surge in demand for the sought-after peptide which could hit the market by the end of this year.

    Lean: Leans left Fact-focusedFactuality: HighCountry: AustraliaFunding: CorporateOwner: Nine Entertainment
+ 3 · Full coverage
Coverage breakdown
Funding
Corporate75%
Public broadcaster25%
Countries
Australia50%
United States50%
Media ownership
Australian Government25%
Nine Entertainment25%
Independent25%
Comcast25%
Avg reliability77
Low-credibility share0%
Fact / opinion7/0
State media0%
More analysis
Truth score: 67 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 4 Reliability: 77 Bias severity: 0 Risk: 0Sentiment: -52Sensationalism: 1 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
1 source

Who is covering this

Sky NewsLeans right
Truth score 431
Right 100%100%
Sky NewsLeans right

'I could've died': The illegal weight-loss drug being sold online

An unlicensed weight-loss drug still undergoing clinical trials in the US is being sold illegally online in the UK, with underground laboratories believed to be producing their own versions. Sky News has found sellers offering bulk...

Lean: Leans right VideoFactuality: HighCountry: United KingdomFunding: CorporateOwner: Comcast
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Comcast100%
Avg reliability80
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 43 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 80 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
3 sources

Who is covering this

ReutersCenterTIMELeans leftQuartzLeans left
Truth score 65
Left 67%67%Centre 33%33%
TIMELeans left

Weight-Loss Drugs May Help Sleep Apnea and Arthritis

Eli Lilly reported results from new studies exploring the effects of its GLP-1 weight-loss drugs on sleep apnea and arthritis. Covered by 3 outlets: 2 lean left, 1 are centre.

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Marc Benioff
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States67%
United Kingdom33%
Media ownership
G/O Media33%
Thomson Reuters33%
Marc Benioff33%
Avg reliability82
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 65 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 3 Reliability: 82 Bias severity: 0 Risk: 0Sentiment: -33Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
1 source

Who is covering this

Fox NewsRight
Truth score 38
Right 100%100%
Fox NewsRight

Popular weight-loss drugs may prevent prediabetes from turning into diabetes

A large study found GLP-1 medications like semaglutide and tirzepatide are linked to 41% lower all-cause mortality risk versus metformin in prediabetes.

Lean: Right Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Fox Corporation
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Fox Corporation100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Science
1 source

Who is covering this

PhysCenter
Truth score 38
Centre 100%100%
PhysCenter

New study examines how diabetes and weight-loss drugs affect employment and working hours

Diabetes and weight-loss medications may have economic effects beyond health care spending, according to new research from NYU Abu Dhabi. Using population-wide data from Denmark, the study found that diabetes treatment caused an...

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like
1 source

Who is covering this

Financial TimesCenter
Truth score 38
Centre 100%100%
Financial TimesCenter

Offshore oil and gas workers turn to weight-loss drugs to meet 124kg limit

Industry safety restrictions on flying out to North Sea facilities to start from November

Lean: Center Fact-focusedFactuality: Mostly factualCountry: IndiaFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Local
1 source

Who is covering this

KIRO-TVNot rated
Truth score 34
No rated outlets yet
KIRO-TVNot rated

GLP-1 poison calls double in Washington as weight-loss drugs surge in popularity

Washington Poison Center reports a spike in calls related to GLP-1 weight loss drugs and unregulated online products.

Lean: Not rated Fact-focusedCountry: United States
Full coverage
Coverage breakdown
Funding
Not recorded100%
Countries
United States100%
Media ownership
KIRO-TV100%
Avg reliability-
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 34 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: Not rated Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
1 source

Who is covering this

QuartzLeans left
Truth score 40
Left 100%100%
QuartzLeans left

Rogaine sales are rising. It might be thanks to weight loss drugs

Kimberly-Clark CEO Mike Hsu said on an earnings call that Rogaine sales are up 30% this year and may reflect use of weight loss drugs

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: G/O Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
G/O Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
3 sources

Who is covering this

ReutersCenterQuartzLeans leftMedscapeCenter
Truth score 63
Left 33%33%Centre 67%67%
ReutersCenter

Lilly to sell obesity drugs directly on Hims & Hers site

Eli Lilly said on Friday it struck a deal to allow Hims & Hers Health to sell obesity drugs Zepbound and Foundayo directly ⁠on its platform, sending the telehealth... Covered by 3 outlets: 1 lean left, 2 are centre.

Lean: Center Fact-focusedFactuality: Very highCountry: United KingdomFunding: CorporateOwner: Thomson Reuters
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States67%
United Kingdom33%
Media ownership
Independent33%
G/O Media33%
Thomson Reuters33%
Avg reliability76
Low-credibility share0%
Fact / opinion3/0
State media0%
More analysis
Truth score: 63 (Corroborated) Propaganda risk: 0 Trending: Low Sources: 3 Reliability: 76 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Business
2 sources

Who is covering this

USA TODAYLeans leftNewsCenter
Truth score 55
Left 50%50%Centre 50%50%
USA TODAYLeans left

Can probiotics help with weight loss? 6 popular options to know

Can probiotics help with weight loss? 6 popular options to know USA Today

Lean: Leans left Fact-focusedFactuality: HighCountry: United StatesFunding: CorporateOwner: Gannett
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States50%
India50%
Media ownership
Gannett50%
Independent50%
Avg reliability72
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 55 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 4 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Weight-Loss Surgery May Yield Long-Term Diabetes Remission

Patients with type 2 diabetes are more likely to reach remission after weight-loss surgery than after intensive lifestyle management, with shorter disease duration linked to better odds of remission.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Weight Loss Linked to Worse Survival in Nonmetastatic RCC

Researchers investigate how weight change after diagnosis and metabolic comorbidities affect survival in patients with nonmetastatic renal cell carcinoma.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

In Weight-Loss Videos, Patients Share Their Experiences

As bariatric surgery rates decline, patient-created weight-loss videos are proliferating on social media. Clinicians advise caution but also see potential benefits.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
World
1 source

Who is covering this

The Epoch TimesRight
Truth score 17Factuality: Low
Right 100%100%
The Epoch TimesRight

First Weight-Loss Tablet Approved for Use in Australia

Low reliability sourceElevated risk

A sign bearing the logo of Novo Nordisk next to the company's factory in Hillerod, Denmark, on Nov. 12, 2025. (Sergei Gapon/AFP via Getty Images)

Lean: Right Fact-focusedFactuality: LowCountry: United StatesFunding: PrivateOwner: Epoch Media Group
Full coverage
Coverage breakdown
Funding
Private100%
Countries
United States100%
Media ownership
Epoch Media Group100%
Avg reliability35
Low-credibility share100%
Fact / opinion1/0
State media0%
More analysis
Truth score: 17 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 35 Bias severity: 0 Risk: 100Sentiment: 0Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
2 sources

Who is covering this

StandardCenterOxfordmailCenter
Truth score 48
Centre 100%100%
StandardCenter

Adverts promoting prescription-only weight loss pills to public are banned

The ads for Voy, Juniper and MedExpress all promoted prescription-only medicines to the public, which is banned in the UK, the ASA found.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 48 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Story Timeline
Like
Health
1 source

Who is covering this

India TodayCenter
Truth score 40
Centre 100%100%
India TodayCenter

Ozempic teeth: Can weight-loss injections damage your teeth and gums?

Ozempic teeth Can weightloss injections damage your teeth and gums

Lean: Center Fact-focusedFactuality: HighCountry: IndiaFunding: CorporateOwner: Living Media
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
India100%
Media ownership
Living Media100%
Avg reliability72
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 40 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 72 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 6 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
1 source

Who is covering this

HellomagazineCenter
Truth score 38
Centre 100%100%
HellomagazineCenter

Vanessa Feltz unveils unbelievable weight loss in ultra-plunging gown before daring leather quickchange

Vanessa Feltz has shown off her impressive weight loss in an ultra-plunging gown of dreams.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 12 Amplification: 0

How we score

Analyze: Compare coverage
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Team-Based Program Aids Weight Loss in Underserved Adults

A 6-month weight-loss pilot program involving doctors, a dietitian, and exercise coaches helped underserved adults with obesity lose a median of 5.5% of body weight.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
1 source

Who is covering this

MedscapeCenter
Truth score 38
Centre 100%100%
MedscapeCenter

Retatrutide Tops Ozempic for Weight Loss, A1c in T2D

In a head-to-head trial, participants with type 2 diabetes lost more than twice as much weight with retatrutide as with Ozempic and had a greater reduction in A1c.

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United StatesFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United States100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Misinfo Radar
Like
Health
2 sources

Who is covering this

The GuardianLeftThe Sydney Morning HeraldLeans left
Truth score 54
Left 100%100%
The GuardianLeft

Australia’s first GLP-1 weight-loss pill has been approved. How much will it cost and where it will it be available?

Wegovy tablets will be going on sale soon as a daily dose after TGA approval, but with restrictions and still plenty of unknowns Get our breaking news email , free app or daily news podcast Australia’s first GLP-1 pill for weight loss...

Lean: Left Fact-focusedFactuality: Very highCountry: United KingdomFunding: Nonprofit trustOwner: Scott Trust
Full coverage
Coverage breakdown
Funding
Nonprofit trust50%
Corporate50%
Countries
Australia50%
United Kingdom50%
Media ownership
Nine Entertainment50%
Scott Trust50%
Avg reliability82
Low-credibility share0%
Fact / opinion2/0
State media0%
More analysis
Truth score: 54 (Limited corroboration) Propaganda risk: 0 Trending: Low Sources: 2 Reliability: 82 Bias severity: 0 Risk: 0Sentiment: 0Sensationalism: 3 Amplification: 0

How we score

Analyze: Story Timeline
Like
Health
1 source

Who is covering this

HellomagazineCenter
Truth score 38
Centre 100%100%
HellomagazineCenter

'00s rapper Fat Joe's unbelievable 250lbs weight loss transformation in staggering photos

Rapper Fat Joe has lost a whopping 250lbs in the last 10 years. See his jaw-dropping weight loss transformation in photos

Lean: Center Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability65
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 38 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 65 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 12 Amplification: 0

How we score

Analyze: Coverage Heat Map
Like
Health
1 source

Who is covering this

Daily ExpressLeans right
Truth score 37
Right 100%100%
Daily ExpressLeans right

Brits given major warning over weight loss injections

Thousands of hopeful dieters are being urged to check their pens after a major raid uncovered dangerous fakes.

Lean: Leans right Fact-focusedFactuality: Mostly factualCountry: United KingdomFunding: CorporateOwner: Independent
Full coverage
Coverage breakdown
Funding
Corporate100%
Countries
United Kingdom100%
Media ownership
Independent100%
Avg reliability62
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 37 (Weakly supported) Propaganda risk: 0 Trending: Low Sources: 1 Reliability: 62 Bias severity: 0 Risk: 0Sentiment: -100Sensationalism: 0 Amplification: 0

How we score

Analyze: Compare coverage
Like